Skip navigation

BME Seminar Series - Wed., Nov. 30

Event Date: November 30, 2016
Hosted By: Weldon School of Biomedical Engineering
Time: 9:30 a.m.
Location: MJIS 1001, WL campus
Priority: No
School or Program: Biomedical Engineering
College Calendar: Show
Andrew J. Saykin, Psy.D., the Raymond C. Beeler Professor of Radiology and Imaging Sciences, Professor of Medical and Molecular Genetics, Director of the Indiana Alzheimer Diseases Center and Director of the Center for Neuroimaging at the Indiana University School of Medicine will present a seminar on Wednesday, November 30th, at 9:30 a.m. in MJIS 1001 entitled "Early Detection of Alzheimer’s Disease: Advances in Neuroimaging, Biomarkers and Genetics."

Abstract: There has been major progress in the understanding of early preclinical and prodromal stages of Alzheimer’s disease (AD).  This seminar will provide an update on what we know and where the field is heading. An increasing emphasis is on integrative systems level analyses spanning elements of memory and cognition, neuroimaging (structural, functional and molecular) and multi –omics data (genome, transcriptome, proteome and metabolome). The discussion will include a progress report on “connecting the dots” and future directions for research aimed at the successful prevention and treatment of AD.

Bio: Dr. Saykin is the Raymond C. Beeler Professor of Radiology and Imaging Sciences at Indiana University School of Medicine where he serves as director of the IU Center for Neuroimaging and the NIA-sponsored Indiana Alzheimer Disease Center.  He is also a cofounder of the new IU Network Science Institute. He also holds appointments in Medical and Molecular Genetics, Neurology and Psychiatry. Dr. Saykin is the Genetics Core leader for the multicenter Alzheimer’s Disease Neuroimaging Initiative (ADNI). He completed his graduate degrees at Hahnemann Medical College in Philadelphia (now Drexel University School of Medicine) and is board-certified in Clinical Neuropsychology. Before joining Indiana University in 2006 he served on the faculties of Dartmouth Medical School and the University of Pennsylvania. Currently, his transdisciplinary research program focuses on the integration of structural, functional and molecular brain imaging with genomic and biomarker methods to identify mechanisms of cognitive dysfunction, potential therapeutic targets and response to treatment in Alzheimer’s disease. Other collaborative federally sponsored projects examine cognitive changes associated with traumatic brain injury, cancer chemotherapy, and schizophrenia. Dr. Saykin is the founding Editor-in-Chief of Brain Imaging and Behavior published by Springer.

Web Links:
Center for Neuroimaging:

Indiana Alzheimer Disease Center:

Indiana Network Science Institute:

ADNI Genetics Core:

Brain Imaging and Behavior:


~BME Faculty Host: Zhongming Liu~

***Coffee and juice will be provided at West Lafayette***